[HTML][HTML] Adenovirus-based vaccines—a platform for pandemic preparedness against emerging viral pathogens

L Coughlan, EJ Kremer, DM Shayakhmetov - Molecular Therapy, 2022 - cell.com
Zoonotic viruses continually pose a pandemic threat. Infection of humans with viruses for
which we typically have little or no prior immunity can result in epidemics with high morbidity …

COVID-19 phase 4 vaccine candidates, effectiveness on SARS-CoV-2 variants, neutralizing antibody, rare side effects, traditional and nano-based vaccine platforms …

FZ Simnani, D Singh, R Kaur - 3 Biotech, 2022 - Springer
The COVID-19 pandemic has endangered world health and the economy. As the number of
cases is increasing, different companies have started developing potential vaccines using …

Exploring the reported adverse effects of COVID-19 vaccines among vaccinated Arab populations: a multi-national survey study

SA Amer, A Al-Zahrani, EA Imam, EM Ishteiwy… - Scientific Reports, 2024 - nature.com
Abstract The coronavirus disease 2019 (COVID-19) pandemic has been a major challenge
worldwide for the past years with high morbidity and mortality rates. While vaccination was …

Cerebral venous disorders: Diagnosis and endovascular management

M Abdalkader, F Hui, MR Amans, E Raz… - Journal of …, 2023 - Elsevier
The role of the venous circulation in neurological diseases has been underestimated. In this
review, we present an overview of the intracranial venous anatomy, venous disorders of the …

Adverse hematological effects of COVID-19 vaccination and pathomechanisms of low acquired immunity in patients with hematological malignancies

AN Yazdani, N DeMarco, P Patel, A Abdi, P Velpuri… - Vaccines, 2023 - mdpi.com
The SARS-CoV-2 virus and the COVID-19 pandemic have spread across the world and
severely impacted patients living with hematological conditions. Immunocompromised …

[HTML][HTML] Global impact of the COVID-19 pandemic on cerebral venous thrombosis and mortality

TN Nguyen, MM Qureshi, P Klein… - Journal of …, 2022 - synapse.koreamed.org
Background and Purpose Recent studies suggested an increased incidence of cerebral
venous thrombosis (CVT) during the coronavirus disease 2019 (COVID-19) pandemic. We …

Acute neurologic complications of COVID-19 and postacute sequelae of COVID-19

NS Dangayach, V Newcombe… - Critical Care …, 2022 - criticalcare.theclinics.com
Neurologic complications of COVID-19 are common. They can occur in patients with mild to
severe COVID-19. Cerebrovascular complications, such as acute ischemic stroke, are seen …

Possible association between Vogt-Koyanagi-Harada disease and coronavirus disease vaccine: A report of four cases

F de Queiroz Tavares Ferreira, DC Araújo… - Ocular Immunology …, 2023 - Taylor & Francis
ABSTRACT Vogt-Koyanagi-Harada (VKH) syndrome is an autoimmune, multisystemic
disease characterized by severe bilateral granulomatous posterior, which can occur due to …

Intracranial dural arteriovenous fistulas

M Abdalkader, TN Nguyen, F Diana… - Seminars in …, 2023 - thieme-connect.com
Dural arteriovenous fistulas (DAVFs) are abnormal communications between meningeal
arteries and dural venous sinuses and/or cortical veins. Although many fistulas are benign …

Diagnosis and treatment of cerebral venous thrombosis

AL Liberman - CONTINUUM: Lifelong Learning in Neurology, 2023 - journals.lww.com
OBJECTIVE Cerebral venous thrombosis (CVT), thrombosis of the dural sinus, cerebral
veins, or both, is a rare cerebrovascular disease. Although mortality rates after CVT have …